Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

April 29, 2014-April 30, 2014

Fifth Annual Patient-Reported Outcome (PRO) Consortium Workshop

Honoring the Past, Navigating the Present, Charting the Future April 29 – 30, 2014 Sheraton Silver Spring Hotel 8777 Georgia Ave

Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future

C-Path’s CEO, Martha A. Brumfield, featured on FasterCures blog

January 4, 2014

Advancing the Portfolio of Tuberculosis Diagnostics, Drugs, Biomarkers, and Vaccines

January 4, 2014

Operationalizing Hippocampal Volume as an Enrichment Biomarker for Amnestic Mild Cognitive Impairment Trials: Effect of Algorithm, Test-Retest Variability, and Cut Point on Trial Cost, Duration, and Sample Size

January 4, 2014

New Antituberculosis Drugs, Regimens, and Adjunct Therapies: Needs, Advances, and Future Prospects

January 4, 2014

Totally-Drug-Resistant Tuberculosis: Hype versus Hope

January 4, 2014

Progress in Tuberculosis Vaccine Development and Host-Directed Therapies–a State of the Art Review

April 2, 2014

Critical Path Institute Receives Grant to Accelerate Development of Tuberculosis Treatments

CFAST Launches Two New CDISC Therapeutic Area Standards

Previous108109 110...130 Next